PreMD Announces Work Force And Operation Reductions
“Over the last while we have faced significant challenges and, with the current economic environment, we are not currently able to continue to finance our clinical or operational
Health innovation platform developer Aditxt and its fully owned subsidiary Ignite Proteomics have announced their plans for a business combination with a strategic partner that values the latter at an implied equity value of nearly $150m.